Crossmark

Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer

Crossref DOI link: https://doi.org/10.1007/s00280-018-3663-z

Published Online: 2018-08-04

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Nishimura, Junichi https://orcid.org/0000-0001-8220-3423
Hasegawa, Junichi

Kato, Takeshi

Yoshioka, Shinichi

Noura, Shingo

Kagawa, Yoshinori

Yasui, Masayoshi

Ikenaga, Masakazu

Murata, Kohei

Hata, Taishi

Matsuda, Chu

Mizushima, Tsunekazu

Yamamoto, Hirofumi

Doki, Yuichiro

Mori, Masaki
License Information

Text and Data Mining valid from 2018-08-04
More Information

Article History

Received: 12 February 2018

Accepted: 2 August 2018

First Online: 4 August 2018

Compliance with ethical standards

:

: The authors have no conflict of interest to declare.